DetailsChartProfileRisk matrixNewsDocuments

Candriam Equities L Biotechnology C - Thesaurierung/  LU0108459040  /

Fonds
NAV2024-12-19 Chg.-4.7100 Type of yield Investment Focus Investment company
849.4700USD -0.55% reinvestment Equity Candriam ▶
     
Chart for Candriam Equities L Biotechnology C - Thesaurierung
  Name   ISIN Performance Volatility Sharpe ratio
1. Janus Henderson Horizon Biotechnology Fund IU2 EUR LU2441282626 +19.16% 20.77% 0.79
2. Polar Capital Funds plc - Biotechnology Fund Class I EUR Distribution Shares IE00B3WVRB16 +18.71% 20.63% 0.77
3. Janus Henderson Horizon Biotechnology Fund A2 EUR LU2441282899 +18.84% 20.99% 0.76
4. Candriam Equities L Biotech.R EUR Acc LU1269736838 +13.47% 18.21% 0.58
5. Candriam Equities L Biotech.I EUR Acc LU1120766032 +12.57% 18.04% 0.54
6. Candriam Equities L Biotech.C EUR LU1120766388 +12.43% 18.20% 0.53
7. J.Henderson H.BioTech.F.IU2 LU1897414568 +13.75% 21.50% 0.51
8. J.Henderson H.BioTech.F.H2 LU1897414485 +13.63% 21.49% 0.50
9. J.Henderson H.BioTech.F.A2 LU1897414303 +13.05% 21.51% 0.47
10. Bellevue Funds (Lux) - Bellevue Obesity Solutions I2 EUR - Accumulating LU1725387622 +7.87% 10.66% 0.47
...
48. Candriam Equities L Biotechnology C - Thesaurierung LU0108459040 +6.27% 17.91% 0.19